Shudi Suoyang Decoction

Shudi Suoyang Decoction is a Traditional Chinese Medicine (TCM) herbal formulation developed by the Beijing Hospital of Traditional Chinese Medicine Affiliated to Capital Medical University. It is primarily investigated for the treatment of progressive fibrosing interstitial lung disease (PF-ILD), specifically in patients presenting with kidney essence deficiency syndrome according to TCM diagnostic criteria. The formulation is typically administered as a granule and is intended to alleviate symptoms such as chronic cough and asthma associated with lung fibrosis. In TCM theory, the primary ingredients Shudi (prepared Rehmannia root) and Suoyang (Cynomorium) are used to tonify the kidneys and replenish essence, which is believed to support lung health and mitigate the progression of fibrotic lung conditions.

Other names

Shudi Suoyang Decoction granule